{
    "Trade/Device Name(s)": [
        "Solana\u00ae Trichomonas Assay"
    ],
    "Submitter Information": "Quidel Corporation",
    "510(k) Number": "K161182",
    "Predicate Device Reference 510(k) Number(s)": [
        "K143329"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OUY"
    ],
    "Summary Letter Date": "July 14, 2016",
    "Summary Letter Received Date": "July 15, 2016",
    "Submission Date": "April 26, 2016",
    "Regulation Number(s)": [
        "21 CFR 866.3860"
    ],
    "Regulation Name(s)": [
        "nucleic acid assay"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Trichomonas vaginalis nucleic acids"
    ],
    "Specimen Type(s)": [
        "Clinician-collected vaginal swab",
        "Female urine"
    ],
    "Specimen Container(s)": [
        "Swab lysis tube",
        "Urine lysis tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Solana\u00ae Instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Isothermal amplification",
        "Helicase-dependent amplification (HDA)",
        "Fluorescent probe detection"
    ],
    "Methodologies": [
        "Nucleic acid amplification test (NAAT)"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Instrument"
    ],
    "Document Summary": "FDA 510(k) summary for Solana\u00ae Trichomonas Assay, an in vitro diagnostic nucleic acid amplification test for detection of Trichomonas vaginalis in vaginal swabs and urine using the Solana instrument",
    "Indications for Use Summary": "Qualitative detection of Trichomonas vaginalis nucleic acids from clinician-collected vaginal swabs and female urine specimens from symptomatic or asymptomatic females to aid in the diagnosis of trichomoniasis, for use only with Solana\u00ae Instrument",
    "fda_folder": "Immunology"
}